BIM
ABEO icon

BlackRock Investment Management’s Abeona Therapeutics ABEO Stock Holding History

BlackRock Investment Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$13K Hold
106
– – ﹤0.01% 3503
2016
Q3 		$16K Hold
106
– – ﹤0.01% 3415
2016
Q2 		$6K Sell
106
-1,707
-94% -$117K ﹤0.01% 3795
2016
Q1 		$116K Buy
1,813
+35
+2% +$2.32K ﹤0.01% 3224
2015
Q4 		$149K Buy
1,778
+14
+0.8% +$1.4K ﹤0.01% 3254
2015
Q3 		$179K Buy
1,764
+243
+16% +$32.3K ﹤0.01% 3258
2015
Q2 		$192K Buy
+1,521
New +$228K ﹤0.01% 3274

Other funds holding ABEO

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock Investment Management's ABEO Position: Q4 2016 in Review

BlackRock Investment Management held its Abeona Therapeutics (ABEO) position steady in Q4 2016 at 106 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #3503.

BlackRock Investment Management first reported a position in ABEO in Q2 2015 and has held it in 7 quarters since. The position peaked at $192K in Q2 2015. 54 funds tracked by Wall St. Rank hold ABEO as of Q4 2016.

  • BlackRock Investment Management held 106 shares of Abeona Therapeutics worth $13K as of Q4 2016.
  • BlackRock Investment Management left its Abeona Therapeutics share count unchanged in Q4 2016.
  • Abeona Therapeutics made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3503 holding.
  • BlackRock Investment Management first reported a position in Abeona Therapeutics in Q2 2015 and has held it in 7 quarters since.
  • BlackRock Investment Management's Abeona Therapeutics position peaked at $192K in Q2 2015.
  • 54 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.